NOVERA RETATRUTIDE: THE NEW SOLUTION FOR WEIGHT MANAGEMENT?

New clinical information suggests that Novera Retatrutide, a combined-action therapy from Novo Nordisk, could represent a substantial advance in body control. Differing from many existing options, Retatrutide affects both glucagon-like peptide-1 (GLP-1) and the GIP hormone, potentially leading to